Sales started to slow in the spring, as market uncertainty began to weigh on investor confidence, says CEO James O’Sullivan ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

Shares Expanded Tech Sector has seen a significant rebound but remains fairly valued with a mixed technical outlook. Learn ...

First Quarter 2025 Results Key Financial Results Revenue: CA$960.9m (up 7.8% from 1Q ...

US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...

IGM Financial Inc. reported adjusted net earnings of $237.8 million for the first quarter, up 5.9% from the same quarter of ...

IGM Financial Inc. (TSX: IGM) held its Annual Meeting of Shareholders earlier today. All of the nominees for election as directors listed in its management proxy circular dated February 24, 2025 were ...

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...

A new multiplex protein microarray has shown promise in accurately detecting a wide range of tick-borne infections in a ...

IGM Financial Inc. reported its Q1 2025 earnings, revealing an adjusted earnings per share (EPS) of $1.00, falling short of analysts’ forecast of $1.05. The company’s revenue also missed expectations, ...